Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration

Cell Transplantation

Volumn 5, Issue 2, 1996, Pages 225-232

  Galpern, W R ^a   Frim, D M ^a   Tatter, S B ^a   Altar, C A ^a   Beal, M F ^a   Isacson, O ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Brain derived neurotrophic factor; Dopamine; MPP+; Neuroprotection; Substantia nigra

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; DOPAMINERGIC NERVE CELL; FETUS; GRAFT SURVIVAL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0029978443     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/0963-6897(95)02030-6     Document Type: Article

References (50)

1. C.A. Altar C.B. Boylan M. Fritsche B.E. Jones C. Jackson S.J. Wiegand R.M. Lindsay C. Hyman Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions J. Neurochem. 63 1994 1021 1032
2. C.A. Altar C.B. Boylan C. Jackson S. Hershenson J. Miller S.J. Wiegand R.M. Lindsay C. Hyman Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo 2nd ed. Proc. Natl. Acad. Sci. USA 89 1992 11347 11351
3. C.A. Altar M. Fritsche P. Holst S. Radke Presence of BDNF protein in brain and plasma detected by a sensitive and specific enzyme-linked immunoassay Soc. Neurosci. Abstr. 21 1995 37
4. 125I]NT-3 Eur. J. Neurosci. 6 1994 1389 1405
5. M.F. Beal W.R. Matson K.J. Swartz P.H. Gamache E.D. Bird Kynurenine pathway measurements in Huntington's disease striatum: Evidence for reduced formation of kynurenic acid J. Neurochem. 55 1990 1327 1339
6. K.D. Beck B. Knusel J.W. Winslow A. Rosenthal L.E. Burton K. Nikolics F. Hefti Pretreatment of dopaminergic neurons in culture with brain-derived neurotrophic factor attenuates toxicity of 1-methyl-4-phenylpyridinium Neurodegeneration 1 1992 27 36
7. K.D. Beck J. Valverde T. Alexi K. Poulsen B. Moffat R.A. Vandlen A. Rosenthal F. Hefti Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain Nature 373 1995 339 341
8. K.J. Campbell M. Takada T. Hattori Evidence for retrograde axonal transport of MPP+ in the rat Neurosci. Lett. 118 1990 151 154
9. J.M. Chirgwin A.E. Brzybyla R.J. Macdonald W.J. Rutter Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease Biochemistry 18 1979 5294 5299
10. D.F. Emerich J.P. Hammang E.E. Baetge S.R. Winn Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections in rodent striatum Exp. Neurol. 130 1994 141 150
11. D.M. Frim R.L. Emanuel B.G. Robinson C.M. Smas G.K. Adler J.A. Majzoub Characterization and gestational regulation of corticotropin-releasing hormone and messenger RNA in the human placenta J. Clin. Invest. 82 1988 293 299
12. D.M. Frim M.P. Short X.O. Breakefield O. Isacson Biological gene-product delivery to the brain: A protocol for retroviral gene transfer into cultured cells and intracerebral transplantation Neuroprotocols: A Companion to Methods in Neurosciences 3 1993 63 68
13. D.M. Frim T.A. Uhler W.R. Galpern M.F. Beal X.O. Breakefield O. Isacson Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat 2nd ed. Proc. Natl. Acad. Sci. USA 91 1994 5104 5108
14. D.M. Frim T.A. Uhler M.P. Short Z.D. Ezzedine M. Klagsbrun X.O. Breakefield O. Isacson Effects of biologically delivered NGF, BDNF, and bFGF in striatal excitotoxic lesions Neuroreport 4 1993 367 370
15. C.M. Gall S.J. Gold P.J. Isackson K.B. Seroogy Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons Mol. Cell. Neurosci. 3 1992 56 63
16. T. Hagg Neurotrophins (BDNF, NT-3, NT-4) prevent death of axotomized adult rat substantia nigra neurons Soc. Neurosci. Abstr. 20 1994 441
17. T. Hagg M. Manthorpe H.L. Vahlsing S. Varon Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage Exp. Neurol. 101 1988 303 312
18. F. Hefti Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections J. Neurosci. 6 1986 2155 2162
19. F. Hefti Neurotrophic factor therapy for nervous system degenerative diseases J. Neurobiol. 25 1994 1418 1435
20. C. Hyman M. Hofer Y.-A. Barde M. Juhasz G.D. Yancopoulos S.P. Squinto R.M. Lindsay BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra Nature 350 1991 230 232
21. C. Hyman M.L. Juhasz C. Jackson P. Wright N.Y. Ip R.M. Lindsay Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon Neuroscience 14 1994 335 347
22. O. Isacson P. Brundin F.H. Gage A. Björklund Neural grafting in a rat model of Huntington's disease: Progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting Neuroscience 16 1985 799 817
23. T.N. Jelsma A.J. Aguayo Trophic factors Curr. Opin. Neurobiol. 4 1994 717 725
24. T.E. Kennedy T. Serafini J.R. de la Torre M. Tessier-Lavigne Netrins are diffusible chemotropic factors for commissural axons in the embryonic spinal cord Cell 787 1994 425 435
25. B. Knusel K.D. Beck J.W. Winslow A. Rosenthal L.E. Burton H.R. Widmer K. Nikolics F. Hefti Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain J. Neurosci. 12 1992 4391 4402
26. B. Knusel J.W. Winslow A. Rosenthal L.E. Burton D.P. Seid K. Nikolics F. Hefti Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3 2nd ed. Proc. Natl. Acad. Sci. USA 88 1991 961 965
27. L.F. Kromer Nerve growth factor treatment after brain injury prevents neuronal death Science 235 1987 214 216
28. B.E. Lams O. Isacson M.V. Sofroniew Loss of transmitter-associated enzyme staining following axotomy does not indicate death of brainstem cholinergic neurons Brain Res. 475 1988 401 406
29. P.A. Lapchak K.D. Beck D.M. Araujo I. Irwin J.W. Langston F. Hefti Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection Neuroscience 53 1993 639 650
30. H. Lehrach D. Diamond J.M. Wozney H. Boedtker RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination Biochemistry 16 1977 4743 4751
31. R.M. Lindsay C.A. Altar J.M. Cedarbaum C. Hyman S.J. Wiegand The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease Exp. Neurol. 124 1993 103 118
32. M.T. Martin-Iverson K.G. Todd C.A. Altar Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interactions with amphetamine J. Neurosci. 14 1994 1262 1270
33. J.-P. Merlio P. Ernfors M. Jaber H. Persson Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system Neuroscience 51 1992 513 532
34. J.K. Morse S.J. Wiegand K. Anderson Y. You N. Cai J. Carnahan J. Miller P.S. Distefano C.A. Altar R.M. Lindsay R.F. Alderson Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection J. Neurosci. 13 1993 4146 4156
35. E.J. Mufson J.S. Kroin T. Sobreviela M.A. Burke J.H. Kordower R.D. Penn J.A. Miller Intrastriatal infusions of brain-derived neurotrophic factor: Retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat Exp. Neurol. 129 1994 15 26
36. W.J. Nicklas S.K. Youngster M.V. Kindt R.E. Heikkila MPTP, MPP+ and mitochondrial function Life Sci. 40 1987 721 729
37. M.B. Rosenberg T. Friedmann R.C. Robertson M. Tuszynski J.A. Wolff X.O. Breakefield F.H. Gage Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression Science 242 1988 1575 1578
38. H. Sauer W. Fischer G. Nikkhah S.J. Wiegand P. Brundin R.M. Lindsay A. Bjorklund Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts Brain Res. 626 1993 37 44
39. J.M. Schumacher M.P. Short B.T. Hyman X.O. Breakefield O. Isacson Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids J. Neurosci. 45 1991 561 570
40. T. Serafini T.E. Kennedy M.J. Galko C. Mirzayan T.M. Jessell M. Tessier-Lavigne The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6 Cell 78 1994 409 424
41. K.B. Seroogy K.H. Lundgren T.M.D. Tran K.M. Guthrie P.J. Isackson C.M. Gall Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs J. Comp. Neurol. 342 1994 321 334
42. R.-Y. Shen C.A. Altar L.A. Chiodo Brain-derived neurotrophic factor increase the electrical activity of pars compacta dopamine neurons in vivo 2nd ed. Proc. Natl. Acad. Sci. USA 91 1994 8920 8924
43. M.B. Spina S.P. Squinto J. Miller R.M. Lindsay C. Hyman Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system J. Neurochem. 59 1992 99 106
44. R. Srivastava E. Brouillet M.F. Beal E. Storey B.T. Hyman Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: A stereological estimate of neuronal loss Neurobiol. Aging 14 1993 295 301
45. H. Takayama J. Ray H.K. Raymon A. Baird J. Hogg L.J. Fisher F.H. Gage Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease Nature Med. 1 1995 53 58
46. A. Tomac E. Lindqvist L.-F.H. Lin S.O. Ögren D. Young B.J. Hoffer L. Olson Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo Nature 373 1995 335 339
47. R. Vejsada Y. Sagot A.C. Kato BDNF-mediated rescue of axotomized motor neurones decreases with increasing dose Neuroreport 5 1994 1889 1892
48. J.L. Venero K.D. Beck F. Hefti Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA Neuroscience 61 1994 257 268
49. L.R. Williams S. Varon G.M. Peterson K. Wictorin W. Fischer A. Bjorklund F.H. Gage Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection 2nd ed. Proc. Natl. Acad. Sci. USA 83 1986 9231 9235
50. D. Wolf C. Richter-Landsberg M.P. Short C. Cepko X.O. Breakefield Retrovirus-mediated gene transfer of beta-nerve growth factor into mouse pituitary line AtT-20 Mol. Biol. Med. 5 1988 43 59